Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...